Haemagglutinin activation by human transmembrane protease serine 2 or by

human airway trypsin-like protease is necessary for the production of high

titre influenza A virus pseudotypes that can be employed for the evaluation of
















































































































































   c leavage	
   arg in ine ,	
   the	
  
haemagglu4nin	
   is	
  cleaved	
  by	
  ubiquitously	
  expressed	
  
sub4lisin-­‐like	
   endoproteases	
   such	
   as	
   furin.	
   This	
  
determines	
   the	
   virulence	
   and	
   lethality	
   for	
   several	
  
avian	
   species	
   observed	
   in	
   the	
   H5	
   and	
   H7	
   highly	
  
pathogenic	
  avian	
   influenza	
  (HPAI)	
  strains	
  [1].	
  On	
  the	
  
other	
   hand,	
   cleavage	
   of	
   low	
   pathogenic	
   avian	
  
influenza	
   (LPAI)	
   strains,	
   human	
   and	
   mammalian	
  
influenza	
  viruses	
  is	
  thought	
  to	
  be	
  mediated	
  by	
  4ssue-­‐
specific	
  proteases.	
  
	
  
Recently,	
   human	
   lung	
   proteases	
   belonging	
   to	
   the	
   serine	
   protease	
   family	
   that	
   are	
   able	
   to	
  
cleave	
   the	
   haemagglu4nin	
   of	
   human	
   influenza	
   strains	
   were	
   iden4fied:	
   Transmembrane	
  
Protease	
  Serine	
  2	
  (TMPRSS2)	
  and	
  Human	
  Airway	
  Trypsin-­‐like	
  protease	
  (HAT)	
  [2].	
  	
  
To	
  study	
  HA	
  	
  ac4va4on,	
  viral	
  entry	
  mechanisms	
  and	
  as	
  surrogate	
  serological	
  an4gens	
  for	
  the	
  
measurement	
   of	
   an4body	
   response	
   directed	
   against	
   the	
   influenza	
   haemagglu4nin,	
  
pseudotype	
  len4viral	
  par4cles	
  are	
  a	
  suitable	
  approach	
  [3].	
  	
  
	
  
MATERIALS	
  AND	
  METHODS	
  
	
  
Len4viral	
   pseudotypes	
   were	
   produced	
   as	
   described	
   previously	
   [4,	
   5].	
   Briefly,	
   HIV	
   gag-­‐pol	
  
plasmid	
   p8.91,	
   firefly	
   luciferase	
   expressing	
   plasmid	
   pCSFLW,	
   HA	
   expressing	
   plasmid	
   and	
  
pCAGGS-­‐TMPRSS2	
   or	
   pCAGGS-­‐HAT	
   [2]	
   were	
   co-­‐transfected	
   into	
   human	
   embryonic	
   kidney	
  
HEK293T/17	
  cells.	
  As	
  control,	
  transfec4ons	
  without	
  the	
  protease	
  plasmids	
  were	
  performed.	
  
Aeer	
  24	
  hours	
  incuba4on,	
  recombinant	
  neuraminidase	
  from	
  Clostridium	
  perfringens	
  (Sigma)	
  
was	
   added	
   (Figure	
  2)	
   to	
   facilitate	
  pseudotype	
  exit	
   from	
   the	
  producer	
   cells.	
   48	
  hours	
  post-­‐
transfec4on	
  supernatant	
  was	
  harvested,	
  filtered	
  through	
  0.45μm	
  filters	
  and	
  stored	
  at	
  -­‐80°C.	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
To	
   test	
   the	
  ability	
  of	
   TMPRSS2	
  and	
  HAT	
   to	
  ac4vate	
  haemagglu4nin,	
  HEK293T/17	
   cells	
   (104	
  
cells/well)	
   were	
   transduced	
   with	
   the	
   pseudotype	
   par4cles	
   produced	
   (Figure	
   3).	
   Aeer	
   48	
  
hours,	
   luminescence	
   of	
   cell	
   cultures	
   (in	
   rela4ve	
   luminescence	
   units)	
   was	
   evaluated	
   by	
  
luminometry	
  using	
   the	
  Bright-­‐Glo	
  assay	
  system	
   (Promega,	
  UK).	
  The	
  pseudotype	
  4tres	
   then	
  
were	
  expressed	
  as	
  RLU/ml.	
  As	
  a	
  control	
  pseudotypes	
  produced	
  in	
  the	
  absence	
  of	
  proteases	
  
were	
   tested	
   for	
   the	
   ability	
   to	
   transduce	
   HEK293T/17	
   cells	
   before	
   and	
   aeer	
   TPCK-­‐Trypsin	
  
(Sigma)	
  treatment	
  at	
  a	
  final	
  concentra4on	
  of	
  50	
  μg/ml.	
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Haemagglu4nin	
  ac4va4on	
  by	
  human	
  transmembrane	
  protease	
  serine	
  2	
  	
  
or	
  human	
  airway	
  trypsin-­‐like	
  protease	
  is	
  necessary	
  	
  
for	
  produc4on	
  of	
  high	
  4tre	
  influenza	
  A	
  virus	
  pseudotypes	
  
for	
  the	
  evalua4on	
  of	
  pandemic	
  poten4al	
  
RESULTS	
  
	
  
We	
  successfully	
  obtained	
  high-­‐4tre	
  viral	
  pseudotype	
  par4cles	
  harbouring	
  the	
  haemagglu4nin	
  
(Figure	
   4	
   and	
   Figure	
   5).	
   The	
   pseudotype	
   par4cle	
   4tres	
   were	
   compared	
   to	
   the	
   controls:	
  
pseudotype	
  par4cles	
  produced	
  without	
  the	
  envelope	
  protein	
  (Δenvelope)	
  and	
  influenza	
  HA	
  
pseudotypes	
  produced	
   in	
   the	
  absence	
  of	
   the	
  protease	
   (Δprotease),	
  before	
  and	
  aeer	
  TPCK-­‐
Trypsin	
  treatment	
  to	
  obtain	
  HA	
  ac4va4on.	
  An	
  H5	
  HPAI	
  influenza	
  strain	
  (A/Vietnam/1194/05)	
  
is	
  also	
  shown	
  as	
  addi4onal	
  control.	
  	
  
Figure	
  1:	
  Phylogene>c	
  rela>onship	
  of	
  
influenza	
  A	
  haemagglu>nin	
  subtypes	
  
Figure	
  3.	
  Pseudotypes	
  transduce	
  HEK293T/17	
  cells	
  aQer	
  HA	
  cleavage	
  and	
  ac>va>on	
  
Figure	
  2:	
  Schema>c	
  representa>on	
  of	
  influenza	
  pseudotype	
  produc>on	
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CONCLUSIONS	
  
	
  
In	
  a	
  prior	
  study	
  with	
  Group-­‐2	
  pseudotypes	
  and	
  using	
  TMPRSS2	
  [6]	
  and	
  in	
  this	
  study	
  we	
  have	
  
shown	
  that:	
  	
  
v  TMPRSS2	
   and	
   HAT	
   func4on	
   in	
   effec4ng	
   the	
   ac4va4on,	
   presumably	
   by	
   cleavage,	
   of	
  
influenza	
  A	
  virus	
  haemagglu4nins	
  to	
  produce	
  high-­‐4tre	
  influenza	
  pseudotypes.	
  
v  Influenza	
  pseudotypes	
   can	
  be	
   employed	
   to	
  determine	
  which	
  proteases	
   are	
   involved	
   in	
  
haemagglu4nin	
  ac4va4on	
  of	
  individual	
  subtypes.	
  
v  Influenza	
  pseudotypes	
  can	
  be	
  used	
  as	
  surrogate	
  an4gens	
  in	
  neutraliza4on	
  assay	
  
FUTURE	
  WORK	
  
v  Use	
  pseudotypes	
  as	
  tools	
  for	
  studying	
  the	
  an4body	
  response	
  induced	
  by	
  vaccina4on	
  and	
  
aeer	
  experimental	
  and	
  natural	
  infec4on	
  (see	
  poster	
  P2-­‐534).	
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Pseudotype	
  par4cles	
  were	
  used	
  as	
  surrogate	
  an4gens	
  in	
  neutraliza4on	
  assay	
  using	
  reference	
  
OIE	
  hyperimmune	
  an4sera	
  or	
  C179	
  monoclonal	
  an4body	
  (Takara)	
  for	
  H1	
  and	
  H2	
  pseudotypes. 
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Figure	
  5.	
  Titres	
  of	
  Group	
  2	
  influenza	
  pseudotype	
  par>cles	
  expressed	
  in	
  Rela>ve	
  Luminescence	
  Units/ml	
  
and	
  pseudotypes	
  neutraliza>on	
  by	
  reference	
  an>sera	
  expressed	
  in	
  Rela>ve	
  Luminescence	
  Units	
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Figure	
  4.	
  Titres	
  of	
  Group	
  1	
  influenza	
  pseudotype	
  par>cles	
  expressed	
  in	
  Rela>ve	
  Luminescence	
  Units/ml	
  
and	
  pseudotypes	
  neutraliza>on	
  by	
  reference	
  an>sera	
  and	
  C179	
  monoclonal	
  an>body	
  (H1	
  and	
  H2)	
  
expressed	
  in	
  Rela>ve	
  Luminescence	
  Units	
  
